The 4-amino analogue of tetrahydrobiopterin efficiently prolongs murine cardiac-allograft survival

Gerald Brandacher, Yiping Zou, Peter Obrist, Wolfgang Steurer, Gabriele Werner-Felmayer, Raimund Margreiter, Ernst R. Werner

Research output: Contribution to journalArticle

Abstract

We tested the 4-amino analogue of tetrahydrobiopterin (H4aminobiopterin), a novel pterin-based inhibitor of nitric oxide synthases, for its efficacy in a murine cardiac-transplant model employing an improved cuff technique. We treated groups of 5 animals each for the first 7 post-operative days with various doses of H4aminobiopterin, with Cyclosporin A (15 mg/kg/day), or no treatment. H4aminobiopterin (3 times 50 mg/kg/day) proved to be as efficient as high-dose Cyclosporin A (15 mg/kg/day) in prolonging allograft survival and in suppressing histologic changes caused by the immunoreaction. Surprisingly, the doses of H4aminobiopterin effective in prolonging allograft survival did not change the plasma nitrite plus nitrate, or the expression of inducible nitric oxide synthase, interferon-γ, tumor necrosis factor-α, and B7-1 (CD80), indicating that H4aminobiopterin may act through a novel, yet undiscovered mechanism.

Original languageEnglish (US)
Pages (from-to)747-749
Number of pages3
JournalJournal of Heart and Lung Transplantation
Volume20
Issue number7
DOIs
StatePublished - Jul 24 2001

    Fingerprint

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation

Cite this